Dermatology Doctors in Coraopolis, PA Accepting Medicare

5 Dermatology doctors found. Showing 1 - 5

Dr. Damon M. Mcclain, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 980 Beaver Grade Rd, Suite 10a, Coraopolis, PA 15108 Phone: 412-262-4911    Fax: 412-262-7856

Dr. Brian Edward Pucevich, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 500 Cherrington Pkwy, Suite 410, Coraopolis, PA 15108 Phone: 412-262-1064    Fax: 412-262-3904

Michael G Osofsky, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 500 Cherrington Pkwy Ste 410, Coraopolis, PA 15108 Phone: 412-262-1064    Fax: 412-262-3904

Dr. Susannah Elizabeth Berke, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 980 Beaver Grade Rd, Suite 10a, Coraopolis, PA 15108 Phone: 412-262-4911

Maria Valiente Pucevich, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 500 Cherrington Pkwy Ste 410, Coraopolis, PA 15108 Phone: 412-262-1064    Fax: 412-262-3904

News Archive

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19

Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19.

Job provides extra emotional support for HIV women to manage their illnesses

Having a job helps women with HIV manage their illnesses, according to researchers from Case Western Reserve University and the University of California at San Francisco.

Peregrine Pharmaceuticals updates on Bavituximab breast cancer study

Peregrine Pharmaceuticals, Inc. has announced that results from a Phase I clinical trial of its lead anti-phosphatidylserine (anti-PS) antibody bavituximab in combination with chemotherapy in patients with advanced cancer were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.

FDA panel supports birth control Yaz but advises labeling changes

Medical experts at the panel of Food and Drug Administration have voted 15-11 that Bayer's Yaz, and Yasmin and similar medications used as birth control pills remain a beneficial option for women, despite an increasing number of studies suggesting the drugs are more likely to cause dangerous blood clots than older birth control pills.

Read more Medical News

› Verified 8 days ago